B. Duda-Król

In vitro angiomodulatory activity of sera from type 2 diabetic patients with background retinopathy.

E. Skopińska-Różewska, J. Szaflik, J. Chorostowska-Wynimko, 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone.

U. Demkow, E. Skopińska-Różewska, J. Szaflik, 2004, International journal of molecular medicine.

Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy.

Anna Lipińska, E. Skopińska-Różewska, J. Szaflik, 2005, Journal of diabetes and its complications.

Serum in vivo angiogenic activity and some pro-angiogenic cytokine levels in diabetes mellitus type 2 (DM2) patients with or without background retinopathy

J. Szaflik, A. Lipińska, J. Chorostowska-Wynimko, 2007 .